Zolmitriptan Tablet, Orally Disintegrating
Product Images NDC 46708-182

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 46708-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

2.5 mg 6 Tablets (Zolmitriptan 25mg)

2.5 mg 6 Tablets (Zolmitriptan 25mg)
FDA Label Image

5 mg 3 Tablets (Zolmitriptan 5mg)

5 mg 3 Tablets (Zolmitriptan 5mg)
FDA Label Image

Figure 1 (Zolmitriptan Figure1)

Figure 1 (Zolmitriptan Figure1)
FDA Label Image

Figure 2 (Zolmitriptan Figure2)

Figure 2 (Zolmitriptan Figure2)
This appears to be a graph or chart showing the estimated probability of remedication or rescue, with percentages ranging from 0% to 100%. There are also different dosages listed, but without further context it is not clear what medication is being referred to. The time axis is labeled in hours.*
FDA Label Image

Figure 3 (Zolmitriptan Figure3)

Figure 3 (Zolmitriptan Figure3)
FDA Label Image

Figure 4 (Zolmitriptan Figure4)

Figure 4 (Zolmitriptan Figure4)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.